Anaemia and malaria

NJ White - Malaria journal, 2018 - Springer
Malaria is a major cause of anaemia in tropical areas. Malaria infection causes haemolysis
of infected and uninfected erythrocytes and bone marrow dyserythropoiesis which …

Biology of malaria transmission

E Meibalan, M Marti - Cold Spring …, 2017 - perspectivesinmedicine.cshlp.org
Understanding transmission biology at an individual level is a key component of intervention
strategies that target the spread of malaria parasites from human to mosquito. Gametocytes …

The ancient gamete fusogen HAP2 is a eukaryotic class II fusion protein

J Fedry, Y Liu, G Pehau-Arnaudet, J Pei, W Li… - Cell, 2017 - cell.com
Sexual reproduction is almost universal in eukaryotic life and involves the fusion of male and
female haploid gametes into a diploid cell. The sperm-restricted single-pass transmembrane …

[HTML][HTML] Safety and immunogenicity of a plant-produced Pfs25 virus-like particle as a transmission blocking vaccine against malaria: A Phase 1 dose-escalation study …

JA Chichester, BJ Green, RM Jones, Y Shoji, K Miura… - Vaccine, 2018 - Elsevier
Malaria continues to be one of the world's most devastating infectious tropical diseases, and
alternative strategies to prevent infection and disease spread are urgently needed. These …

Immunogenicity studies of proteins forming the T4 phage head surface

K Dąbrowska, P Miernikiewicz, A Piotrowicz… - Journal of …, 2014 - Am Soc Microbiol
Advances in phage therapy and novel applications of phages in biotechnology encourage
interest in phage impact on human and animal immunity. Here we present comparative …

Malaria eradication and elimination: views on how to translate a vision into reality

M Tanner, B Greenwood, CJM Whitty, EK Ansah… - BMC medicine, 2015 - Springer
Although global efforts in the past decade have halved the number of deaths due to malaria,
there are still an estimated 219 million cases of malaria a year, causing more than half a …

Transmission-blocking vaccines: harnessing herd immunity for malaria elimination

PE Duffy - Expert Review of Vaccines, 2021 - Taylor & Francis
Introduction Transmission-blocking vaccines (TBV) prevent community spread of malaria by
targeting mosquito sexual stage parasites, a life-cycle bottleneck, and will be used in …

Immunity against sexual stage Plasmodium falciparum and Plasmodium vivax parasites

RM de Jong, SK Tebeje… - Immunological …, 2020 - Wiley Online Library
The efficient spread of malaria from infected humans to mosquitoes is a major challenge for
malaria elimination initiatives. Gametocytes are the only Plasmodium life stage infectious to …

Oral application of T4 phage induces weak antibody production in the gut and in the blood

J Majewska, W Beta, D Lecion, K Hodyra-Stefaniak… - Viruses, 2015 - mdpi.com
A specific humoral response to bacteriophages may follow phage application for medical
purposes, and it may further determine the success or failure of the approach itself. We …

A potent and durable malaria transmission-blocking vaccine designed from a single-component 60-copy Pfs230D1 nanoparticle

ND Salinas, R Ma, TH Dickey, H McAleese, T Ouahes… - npj Vaccines, 2023 - nature.com
Malaria transmission-blocking vaccines (TBVs) reduce disease transmission by breaking the
continuous cycle of infection between the human host and the mosquito vector. Domain 1 …